Risofos 35 Tablet (Risedronate 35mg)

What is Risofos 35 Tablet (Risedronate 35mg)?

Risofos 35 Tablet contains risedronate sodium, a bisphosphonate medication used to treat and prevent osteoporosis in postmenopausal women and men at increased risk of bone fractures. It works by slowing bone loss, helping maintain bone density, and reducing the likelihood of fractures, especially in the spine and hip. This once-weekly tablet is most effective when combined with adequate calcium and vitamin D intake.

Key features

• Active Ingredient — Risedronate 35mg per tablet for effective bone resorption inhibition.
• Dosing Schedule — Once-weekly dosing improves medication adherence.
• Bone Density Support — Clinically shown to increase bone mineral density over time.
• Fracture Risk Reduction — Reduces risk of vertebral and non-vertebral fractures.
• Prescription-Based — Requires medical evaluation and supervision for safe use.
• Oral Tablet Form — Convenient oral administration with specific intake instructions.
• Brand Consistency — Manufactured to meet pharmaceutical quality standards.

Who is Risofos 35 Tablet (Risedronate 35mg) for?

This medication is intended for postmenopausal women, men with osteoporosis, and individuals at high risk of fractures due to low bone mass. It's suitable for patients able to follow dosing instructions, such as remaining upright and fasting for 30 minutes after intake. Not recommended for those with severe kidney disease or esophageal disorders.

How does Risofos 35 Tablet (Risedronate 35mg) compare?

Compared to daily bisphosphonates, Risofos 35 offers a more convenient weekly dosing schedule. It performs similarly to other risedronate brands and compares favorably with alendronate-based treatments in fracture reduction. Unlike injectable osteoporosis drugs, it avoids needles but requires strict oral intake guidelines. It is not interchangeable with calcium supplements or hormone therapies.